EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Microbial Dysbiosis and Immune–Barrier Interactions in Atopic Dermatitis: A Review

Nurul Ain Mohd Noor, Nur Najibah Yusra Sulaiman, Siong Meng Lim, Kalavathy Ramasamy, Muhamad Fareez Ismail

Science Letters · 02.01.2026 · 20 (1) · 59-74

DOI: 10.24191/scl.v20i1.8715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, online erschienen am 02.01.2026. Verfasst von Nurul Ain Mohd Noor und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a multifactorial inflammatory skin disease characterised by immune dysregulation, skin barrier dysfunction, and microbial imbalance, which collectively contribute to a substantial global health burden. Epidemiological evidence shows increasing prevalence worldwide, with pronounced rises in urbanised Asian populations and early childhood. Advances in molecular and multi-omics approaches have transformed skin microbiome research, revealing consistent patterns of reduced microbial diversity and dominance of Staphylococcus aureus, alongside complex interactions with protective commensals such as Staphylococcus epidermidis. These microbial shifts exacerbate type 2 immune responses and barrier disruption, establishing a self-perpetuating cycle of chronic inflammation. Advances in molecular and multi-omics approaches have enhanced understanding of AD heterogeneity, linking genetic factors, skin barrier impairment, and immune–microbiome interactions to disease pathogenesis. This review summarises current insights into the role of the microbiome in AD, emphasising host–microbe interactions, geographic and ethnic differences, and novel therapeutic opportunities targeting microbial modulation. Future progress requires harmonised, multicentre, longitudinal studies that integrate immunological, genetic, microbial, and barrier-related data to unravel AD complexity. Such approaches will enable precision medicine strategies and robust evaluation of novel interventions, addressing a critical need for effective and tailored therapies across diverse populations.

Zitieren

APA

Noor, N. A. M., Sulaiman, N. N. Y., Lim, S. M., Ramasamy, K., & Ismail, M. F. (2026). Microbial Dysbiosis and Immune–Barrier Interactions in Atopic Dermatitis: A Review. Science Letters, 20(1), 59-74. https://doi.org/10.24191/scl.v20i1.8715

Vancouver

Noor NAM, Sulaiman NNY, Lim SM, Ramasamy K, Ismail MF. Microbial Dysbiosis and Immune–Barrier Interactions in Atopic Dermatitis: A Review. Science Letters. 2026;20(1):59-74. doi:10.24191/scl.v20i1.8715

BibTeX
@article{Noor2026,
  author = {Noor, Nurul Ain Mohd and Sulaiman, Nur Najibah Yusra and Lim, Siong Meng and Ramasamy, Kalavathy and Ismail, Muhamad Fareez},
  title = {Microbial Dysbiosis and Immune–Barrier Interactions in Atopic Dermatitis: A Review},
  journal = {Science Letters},
  year = {2026},
  volume = {20},
  number = {1},
  pages = {59--74},
  doi = {10.24191/scl.v20i1.8715}
}
Kostenlos starten →